Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transplant Tolerance and Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver
NCT07735650Enrolling by invitation
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial in liver transplantation, sponsored by Chang Gung Memorial Hospital. Primary endpoint: Percentage of Recipient Cells in the Liver Allograft at 1 year. Started Aug 2025; status: enrolling by invitation.
02
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT07735650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07735650.